𝔖 Bobbio Scriptorium
✦   LIBER   ✦

N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial

✍ Scribed by Lakshmi Rajdev; Zi-Fan Yu; Scott Wadler; Edie Weller; S. Benham Kahn; Douglass Tormey; Roland Skeel; Peter H. Wiernik


Book ID
110294216
Publisher
Springer US
Year
2001
Tongue
English
Weight
61 KB
Volume
19
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of PCNU in advanced malig
✍ Robert H. Earhart; Franco M. Muggia; Frederick M. Golomb πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 327 KB

PCNU, a chloroethylnitrosourea with high alkylating activity, low carbamoylating activity, optimal octanol: water partition coefficient and broad activity in animal systems, was administered to 32 evaluable patients with measurable metastatic melanoma by brief intravenous infusions every six weeks.

An eastern cooperative oncology group ph
✍ Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 2 views

## Background. Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.

Phase II trial of gemcitabine in patient
✍ Scott Okuno; Louise M. Ryan; John H. Edmonson; Dennis A. Priebat; Ronald H. Blum πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twenty‐five patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo